Carmena Trial: Should Nephrectomy Be Standard for Metastatic RCC?

In this randomized phase III trial, researchers compared cytoreductive nephrectomy vs  sunitinib alone in patients with metastatic renal cell carcinoma.

Source: CancerNetwork - June 10, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news